New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
05:09 EDTCTICCell Therapeutics approves amendment of shareholder rights plan
Cell Therapeutics announced that its board has approved certain amendments to CTI's existing shareholder rights plan to decrease the exercise price of the preferred stock purchase rights under the Rights Plan from $14.00 to $8.00 and to extend the "final expiration date" from the close of business on the third anniversary of January 7, to the close of business on December 3, 2015. The Rights were initially distributed as a dividend on each share of CTI's common stock outstanding on the Record Date and currently trade with each outstanding share of CTI's common stock.
News For CTIC From The Last 14 Days
Check below for free stories on CTIC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
09:10 EDTCTICOn The Fly: Pre-market Movers
Subscribe for More Information
05:31 EDTCTICCTI BioPharma to host conference call
Subscribe for More Information
05:18 EDTCTICCTI BioPharma, Servier enter exclusive PIXUVRI license, collaboration agreement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use